Nevertheless, use of PDE10 inhibitors may have additional therapeutic advantages as PDE10A is involved into the pathology of cardiovascular diseases: heart failure and pulmonary arterial hypertension. This evidence concerns the gene PDE10A and pulmonary arterial hypertension.